{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:09:26Z","timestamp":1794258566957,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autologous platelet concentrates (PRP, PRF, i-PRF) represent blood-derived biomaterials that have been reported to exhibit antimicrobial activity against oral microorganisms in vitro. In diffusion-based assays, visualization of inhibitory effects depends not only on bacterial growth but also on matrix-dependent diffusion behavior within the surrounding culture medium, particularly those complex media used for fastidious anaerobic species. However, it remains unclear whether commonly used agar media provide comparable assay environments for evaluating APC-derived antimicrobial effects. This feasibility study therefore investigated whether PRP, PRF and i-PRF generate measurable inhibition zones on different agar matrices and whether medium selection influences inhibition detectability and measurable zone expression in diffusion-based assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Inhibitory effects of PRP, PRF and i-PRF against\n                      <jats:italic>Porphyromonas gingivalis<\/jats:italic>\n                      and\n                      <jats:italic>Prevotella intermedia<\/jats:italic>\n                      were tested on Brucella blood agar (BBA), Mueller\u2013Hinton blood agar and Tryptic Soy Agar supplemented with blood (TSASB). Only measurable inhibition zones were included in quantitative analyses, while detectability outcomes were assessed separately.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BBA produced significantly larger measurable inhibition zones for\n                      <jats:italic>P. gingivalis<\/jats:italic>\n                      compared with TSASB (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0006; Cliff\u2019s \u03b4\u2009=\u20090.92). For\n                      <jats:italic>P. intermedia<\/jats:italic>\n                      , BBA and MHB showed comparable inhibition patterns (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.77), whereas TSASB yielded no measurable inhibition zones. Inhibition effects were detectable for all investigated platelet preparations. Exploratory comparisons between PRP, PRF and i-PRF across culture media did not reveal statistically significant differences under the present experimental conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Agar composition represents an active experimental matrix in diffusion assays and critically shapes inhibition zone expression, particularly for strict anaerobic periodontal pathogens. Culture medium selection therefore constitutes a key methodological variable in antimicrobial evaluation of APCs, and negative findings in diffusion assays should be interpreted cautiously within the context of the underlying assay environment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-026-08768-8","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:27:46Z","timestamp":1780410466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Culture medium influences detectability of antimicrobial effects of autologous platelet concentrates against anaerobic periodontal pathogens"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-4052","authenticated-orcid":false,"given":"Ellen E.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-040X","authenticated-orcid":false,"given":"Andreas","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-3939","authenticated-orcid":false,"given":"Patrick","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-5294","authenticated-orcid":false,"given":"Georg","family":"Conrads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"8768_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/antibiotics15020173","volume":"15","author":"EE Jansen","year":"2026","unstructured":"Jansen EE, Hejazi Z, Braun A, Jansen P, Conrads G. In Vitro Antimicrobial Potential of Different Platelet Concentrates Against Eight Clinically Relevant Oral Pathobionts. Antibiot (Basel). 2026;15:173. https:\/\/doi.org\/10.3390\/antibiotics15020173.","journal-title":"Antibiot (Basel)"},{"key":"8768_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrmicro3269","volume":"12","author":"MR Yeaman","year":"2014","unstructured":"Yeaman MR, Platelets. At the Nexus of Antimicrobial Defence. Nat Rev Microbiol. 2014;12:426\u201337. https:\/\/doi.org\/10.1038\/nrmicro3269.","journal-title":"Nat Rev Microbiol"},{"key":"8768_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/biomedicines9080869","volume":"9","author":"EE Jansen","year":"2021","unstructured":"Jansen EE, Braun A, Jansen P, Hartmann M. Platelet-Therapeutics to Improve Tissue Regeneration and Wound Healing\u2014Physiological Background and Methods of Preparation. Biomedicines. 2021;9:869. https:\/\/doi.org\/10.3390\/biomedicines9080869.","journal-title":"Biomedicines"},{"key":"8768_CR4","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.3390\/ijms221910230","volume":"22","author":"AS Aquino-Dom\u00ednguez","year":"2021","unstructured":"Aquino-Dom\u00ednguez AS, Romero-Tlalolini MDLA, Torres-Aguilar H, Aguilar-Ruiz SR. Recent Advances in the Discovery and Function of Antimicrobial Molecules in Platelets. IJMS. 2021;22:10230. https:\/\/doi.org\/10.3390\/ijms221910230.","journal-title":"IJMS"},{"key":"8768_CR5","doi-asserted-by":"publisher","first-page":"722499","DOI":"10.3389\/fcimb.2021.722499","volume":"11","author":"F Rodr\u00edguez S\u00e1nchez","year":"2021","unstructured":"Rodr\u00edguez S\u00e1nchez F, Verspecht T, Castro AB, Pauwels M, Andr\u00e9s CR, Quirynen M, Teughels W. Antimicrobial Mechanisms of Leucocyte- and Platelet Rich Fibrin Exudate Against Planktonic Porphyromonas Gingivalis and Within Multi-Species Biofilm: A Pilot Study. Front Cell Infect Microbiol. 2021;11:722499. https:\/\/doi.org\/10.3389\/fcimb.2021.722499.","journal-title":"Front Cell Infect Microbiol"},{"key":"8768_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/0970-9290.186231","volume":"27","author":"PS Badade","year":"2016","unstructured":"Badade PS, Mahale SA, Panjwani AA, Vaidya PD, Warang AD. Antimicrobial Effect of Platelet-Rich Plasma and Platelet-Rich Fibrin. Indian J Dent Res. 2016;27:300\u20134. https:\/\/doi.org\/10.4103\/0970-9290.186231.","journal-title":"Indian J Dent Res"},{"key":"8768_CR7","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1038\/s41598-019-44755-6","volume":"9","author":"AB Castro","year":"2019","unstructured":"Castro AB, Herrero ER, Slomka V, Pinto N, Teughels W, Quirynen M. Antimicrobial Capacity of Leucocyte-and Platelet Rich Fibrin against Periodontal Pathogens. Sci Rep. 2019;9:8188. https:\/\/doi.org\/10.1038\/s41598-019-44755-6.","journal-title":"Sci Rep"},{"key":"8768_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/09537104.2015.1116686","volume":"27","author":"MD Fabbro","year":"2016","unstructured":"Fabbro MD, Bortolin M, Taschieri S, Ceci C, Weinstein RL. Antimicrobial Properties of Platelet-Rich Preparations. A Systematic Review of the Current Pre-Clinical Evidence. Platelets. 2016;27:276\u201385. https:\/\/doi.org\/10.3109\/09537104.2015.1116686.","journal-title":"Platelets"},{"key":"8768_CR9","doi-asserted-by":"publisher","unstructured":"Moraschini V, Miron RJ, Mour\u00e3o CFDAB, Louro RS, Sculean A, da Fonseca LAM, Calasans Maia MD, Shibli JA. Antimicrobial Effect of Platelet-rich Fibrin: A Systematic Review of in Vitro Evidence\u2010based Studies. Periodontol 2000. 2024;94(131\u2013142). https:\/\/doi.org\/10.1111\/prd.12529.","DOI":"10.1111\/prd.12529"},{"key":"8768_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51360","author":"C Karan","year":"2023","unstructured":"Karan C, Jeyaraman M, Jeyaraman N, Ramasubramanian S, Khanna M, Yadav S. Antimicrobial Effects of Platelet-Rich Plasma and Platelet-Rich Fibrin: A Scoping Review. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.51360.","journal-title":"Cureus"},{"key":"8768_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jac\/dkn090","volume":"61","author":"B Bonev","year":"2008","unstructured":"Bonev B, Hooper J, Parisot J. Principles of Assessing Bacterial Susceptibility to Antibiotics Using the Agar Diffusion Method. J Antimicrob Chemother. 2008;61:1295\u2013301. https:\/\/doi.org\/10.1093\/jac\/dkn090.","journal-title":"J Antimicrob Chemother"},{"key":"8768_CR12","unstructured":"EUCAST. The EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing. Version 13.0. European Committee on Antimicrobial Susceptibility Testing. 2025."},{"key":"8768_CR13","unstructured":"CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests. CLSI Standard M02. (13th Ed.;CLSI: Wayne, PA, USA, 2018)."},{"key":"8768_CR14","doi-asserted-by":"publisher","first-page":"1412e1","DOI":"10.1016\/j.cmi.2020.01.018","volume":"26","author":"J \u00c5hman","year":"2020","unstructured":"\u00c5hman J, Matuschek E, Kahlmeter GEUCAST. Evaluation of 21 Brands of Mueller\u2013Hinton Dehydrated Media for Disc Diffusion Testing. Clin Microbiol Infect. 2020;26:1412e1. 1412.e5.","journal-title":"Clin Microbiol Infect"},{"key":"8768_CR15","doi-asserted-by":"publisher","first-page":"O255","DOI":"10.1111\/1469-0691.12373","volume":"20","author":"E Matuschek","year":"2014","unstructured":"Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST Disk Diffusion Antimicrobial Susceptibility Testing Method and Its Implementation in Routine Microbiology Laboratories. Clin Microbiol Infect. 2014;20:O255\u201366. https:\/\/doi.org\/10.1111\/1469-0691.12373.","journal-title":"Clin Microbiol Infect"},{"key":"8768_CR16","doi-asserted-by":"publisher","unstructured":"Belibasakis GN, Belstr\u00f8m D, Eick S, Gursoy UK, Johansson A, K\u00f6n\u00f6nen E. Periodontal Microbiology and Microbial Etiology of Periodontal Diseases: Historical Concepts and Contemporary Perspectives. Periodontol 2000. 2023;prd12473. https:\/\/doi.org\/10.1111\/prd.12473.","DOI":"10.1111\/prd.12473"},{"key":"8768_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1753425908101920","volume":"15","author":"K Hyv\u00e4rinen","year":"2009","unstructured":"Hyv\u00e4rinen K, Laitinen S, Paju S, Hakala A, Suominen-Taipale L, Skurnik M, K\u00f6n\u00f6nen E, Pussinen PJ. Detection and Quantification of Five Major Periodontal Pathogens by Single Copy Gene-Based Real-Time PCR. Innate Immun. 2009;15:195\u2013204. https:\/\/doi.org\/10.1177\/1753425908101920.","journal-title":"Innate Immun"},{"key":"8768_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41579-018-0089-x","volume":"16","author":"RJ Lamont","year":"2018","unstructured":"Lamont RJ, Koo H, Hajishengallis G. The Oral Microbiota: Dynamic Communities and Host Interactions. Nat Rev Microbiol. 2018;16:745\u201359. https:\/\/doi.org\/10.1038\/s41579-018-0089-x.","journal-title":"Nat Rev Microbiol"},{"key":"8768_CR19","doi-asserted-by":"publisher","unstructured":"How KY, Song KP, Chan KG. Porphyromonas Gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front Microbiol. 2016;7. https:\/\/doi.org\/10.3389\/fmicb.2016.00053.","DOI":"10.3389\/fmicb.2016.00053"},{"key":"8768_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1574-6968.1998.tb13003.x","volume":"162","author":"K-P Leung","year":"1998","unstructured":"Leung K-P, Subramaniam PS, Okamoto M, Fukushima H, Lai C-H. The Binding and Utilization of Hemoglobin by Prevotella Intermedia. FEMS Microbiol Lett. 1998;162:227\u201333. https:\/\/doi.org\/10.1111\/j.1574-6968.1998.tb13003.x.","journal-title":"FEMS Microbiol Lett"},{"key":"8768_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/jid.jid_66_20","volume":"11","author":"VR Balaji","year":"2021","unstructured":"Balaji VR, Thiagarajan RK, Niazi TM, Ulaganathan G, Manikandan D. Antimicrobial Effects of Platelet Rich Fibrin: A Systematic Review on Current Evidence of Research. J Interdisciplinary Dentistry. 2021;11:2\u201310. https:\/\/doi.org\/10.4103\/jid.jid_66_20.","journal-title":"J Interdisciplinary Dentistry"},{"key":"8768_CR22","doi-asserted-by":"publisher","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","DOI":"10.1001\/jama.2013.281053"},{"key":"8768_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock REW. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances. Nat Protoc. 2008;3:163\u201375. https:\/\/doi.org\/10.1038\/nprot.2007.521.","journal-title":"Nat Protoc"},{"key":"8768_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","volume":"6","author":"M Balouiri","year":"2016","unstructured":"Balouiri M, Sadiki M, Ibnsouda SK. Methods for in Vitro Evaluating Antimicrobial Activity: A Review. J Pharm Anal. 2016;6:71\u20139. https:\/\/doi.org\/10.1016\/j.jpha.2015.11.005.","journal-title":"J Pharm Anal"},{"key":"8768_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-291X(02)02826-7","volume":"300","author":"Y Shibata","year":"2003","unstructured":"Shibata Y, Hiratsuka K, Hayakawa M, Shiroza T, Takiguchi H, Nagatsuka Y, Abiko Y. A 35-kDa Co-Aggregation Factor Is a Hemin Binding Protein in Porphyromonas Gingivalis. Biochem Biophys Res Commun. 2003;300:351\u20136. https:\/\/doi.org\/10.1016\/S0006-291X(02)02826-7.","journal-title":"Biochem Biophys Res Commun"},{"key":"8768_CR26","doi-asserted-by":"publisher","first-page":"e111168","DOI":"10.1371\/journal.pone.0111168","volume":"9","author":"CA Butler","year":"2014","unstructured":"Butler CA, Dashper SG, Zhang L, Seers CA, Mitchell HL, Catmull DV, Glew MD, Heath JE, Tan Y, Khan HSG, et al. The Porphyromonas Gingivalis Ferric Uptake Regulator Orthologue Binds Hemin and Regulates Hemin-Responsive Biofilm Development. PLoS ONE. 2014;9:e111168. https:\/\/doi.org\/10.1371\/journal.pone.0111168.","journal-title":"PLoS ONE"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08768-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:18:30Z","timestamp":1781965110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08768-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8768"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08768-8","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local ethics committee (CTC-A-Nr.21\u2013329, EK 379\/21, RWTH Aachen University) and conducted in accordance with the Declaration of Helsinki [\n                      \n                      ]. All participants provided written informed consent, and samples were anonymized prior to analysis. Clinical trial number: Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1090"}}